ICD-10-CM Diagnosis Code C16.2 - Malignant neoplasm of body of stomach (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- C00–D49
- C15-C26
- C16
- 2026 ICD-10-CM Code C16.2
Malignant neoplasm of body of stomach
ICD-10-CM Code:
C16.2
ICD-10 Code for:
Malignant neoplasm of body of stomach
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:
C16.2 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of body of stomach. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic corpus gastric or Neoplasm, neoplastic stomach body or Neoplasm, neoplastic stomach corpus .
- Code Information
- Approximate Synonyms
- Clinical Classification
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Convert to ICD-9 Code
- Table of Neoplasms
- Patient Education
- Other Codes Used Similar Conditions
- Code History
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
- Carcinoma of body of stomach
- Leiomyosarcoma of gastric corpus structure
- Leiomyosarcoma of stomach
- Lymphoma of body of stomach
- Malignant neoplasm of body of stomach
- Primary adenocarcinoma of body of stomach
- Primary carcinoma of body of stomach
- Primary malignant neoplasm of body of stomach
Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.
They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.
CCSR Code: NEO013
Inpatient Default: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.
ICD-9-CM: 151.4
This is a direct match with no additional mapping qualifiers. The absence of a flag generally means the mapping is considered exact or precise. In other words, the ICD-10 code maps cleanly to the ICD-9 code without qualification, approximation, or needing multiple codes.
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Filter table of neoplasms:
| Neoplasm, neoplastic | Malignant Primary | Malignant Secondary | CaInSitu | Benign | Uncertain Behavior | Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »corpus »gastric | C16.2 | C78.89 | D00.2 | D13.1 | D37.1 | D49.0 |
| »Neoplasm, neoplastic »stomach »body | C16.2 | C78.89 | D00.2 | D13.1 | D37.1 | D49.0 |
| »Neoplasm, neoplastic »stomach »corpus | C16.2 | C78.89 | D00.2 | D13.1 | D37.1 | D49.0 |
Stomach Cancer
The stomach is an organ between the esophagus and the small intestine. It mixes food with stomach acid and helps digest protein. Stomach cancer mostly affects older people - two-thirds of people who have it are over age 65. Your risk of getting it is also higher if you:
- Have had a Helicobacter pylori infection
- Have had stomach inflammation
- Are a man
- Eat lots of salted, smoked, or pickled foods
- Smoke cigarettes
- Have a family history of stomach cancer
It is hard to diagnose stomach cancer in its early stages. Indigestion and stomach discomfort can be symptoms of early cancer, but other problems can cause the same symptoms. In advanced cases, there may be blood in your stool, vomiting, unexplained weight loss, jaundice, or trouble swallowing. Doctors diagnose stomach cancer with a physical exam, blood and imaging tests, an endoscopy, and a biopsy.
Because it is often found late, it can be hard to treat stomach cancer. Treatment options include surgery, chemotherapy, radiation or a combination.
NIH: National Cancer Institute
What is Stomach Cancer?
Learn about stomach cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, treatment, and coping.
[Learn More in MedlinePlus]
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
